Idexx Laboratories Announces CEO Jonathan Ayers’ Resignation
Company Announcements

Idexx Laboratories Announces CEO Jonathan Ayers’ Resignation

Idexx Laboratories ( (IDXX) ) has shared an update.

Jonathan W. Ayers, former Chairman and CEO of IDEXX Laboratories, has resigned from the Board, effective November 8, 2024, after over two decades of service. His departure was amicable, not stemming from any company disagreements, and the Board will reduce from eleven to ten members. Ayers, who played a pivotal role in the company’s growth, is thanked for his valuable contributions.

For a thorough assessment of IDXX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyIdexx Laboratories price target lowered to $435 from $520 at Piper Sandler
TheFlyIdexx Laboratories price target lowered to $481 from $570 at Barclays
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App